Publications

View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.

April 2014

Hipoksi ve STAT3 sinyalizasyonunun etkileşimleri romatoid artritte proinflamatuvar yolları düzenler

. ARD published online first 13 Feb 2014. Doi: 10.1136/annrheumdis-2013-204105

Gao W,

McCormick J,

Connolly M et al.

Hypoxia is a key driving force in joint inflammation, however little is known about the effect it can have on JAK/STAT signalling in rheumatoid arthritis. Due to the development of JAK inhibitors as therapeutics it is important to understand any links there may be. Previous studies have shown that HIF1a, a protein associated with hypoxia, facilitates the binding of STAT3 to haptoglobin promoter in HepG2 human hepatoma cells. HIF1a also requires interaction of Notch signalling pathways with STAT3...

Keywords:

February 2014

Januz kinaz inhibitörü Tofasitinibin insanlarda farmakokinetik, metabolizma ve klirens mekanizması

DMD doi:10.1124/dmd.113.054940

Dowty ME,

Lin J,

Ryder TF et al

The PK of tofacitinib has previously been described in several papers covering a range of diseases. This current study was used to better understand the PK, metabolism and clearance mechanisms of tofacitinib in healthy human subjects. Six subjects took a single 50mg dose of 14C-tofacitinib orally and consequently had urine, faeces and plasma collected. These were assayed for radioactivity and profiled for metabolites. Tofacitinib was found to be rapidly absorbed, with peak plasma concentrations ...

Keywords:

January 2014

Romatoid Artrit de kritik hücre tipleri ve yolaklarının anlaşılmasında genom ilişki çalışmalarının öncüllüğü: Son bulgular ve zorluklar

Curr. Opin. Rheumatol. 2014; 26:85–92. doi:10.1097/BOR.0000000000000012

Diogo D,

Okada Y,

Plenge RM

A large number of loci implicated in disease susceptibility have been identified through genome-wide association studies (GWAS). In this review article, Diogo et al. discuss recent advances in GWAS in the context of rheumatoid arthritis pathogenesis and clinical applications. Relevant cells types and pathways in RA highlighted by GWAS to date include regulatory T-cells and CD4+ memory T cells as well as the JAK/STAT and NF-kB signalling pathways. The development of drugs targeting these pathways...